Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray

Author(s):
Woittiez, N.J.C.; Roep, B.O.
Published
2015
Publication type
Article / Letter to editor
disease heterogeneityheterogeneityimmunotherapypersonalized medicineType 1 diabetes
Date issued
2015-12-31
Language
English
Is part of
Immunotherapy (2015), Vol. 7, no. 2, p. 163-174
hdl
1887/104629
doi
10.2217/imt.14.104